Get the Stockscreener App
71.19
0.90%
-0.65
After Hours:
71.19
Lantheus Holdings Inc stock is traded at $71.19, with a volume of 696.91K.
It is down -0.90% in the last 24 hours and down -13.03% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$71.84
Open:
$71.05
24h Volume:
696.91K
Relative Volume:
0.60
Market Cap:
$4.93B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
11.85
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
+0.37%
1M Performance:
-13.03%
6M Performance:
-23.05%
1Y Performance:
-32.09%
1-Day Range:
$70.77
$72.00
1-Week Range:
$70.77
$73.52
52-Week Range:
$69.12
$118.21
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
71.19 | 4.97B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
What makes Lantheus Holdings Inc. stock price move sharplyRetirement Planning Growth Plan With Proven Results - jammulinksnews.com
Lantheus Expands Bedford Footprint with New 41,000-SF Office Lease, BBJ Reports - Boston Real Estate Times
Short interest data insights for Lantheus Holdings Inc.Fast Exit and Entry Strategy Guide Offered - metal.it
How high can Lantheus Holdings Inc. stock price go in 2025Entry Alert With Low Drawdown Strategy Noted - metal.it
Will Lantheus Holdings Inc. stock benefit from interest rate changesSmart Allocation Stock Pick Insights Gaining Interest - beatles.ru
Lantheus Holdings Expands Alzheimer’s Diagnostics Despite Recent Stock Dip - MSN
Riley Reduces Lantheus Holdings (LNTH) PT to $109, Maintains Buy Rating - MSN
What are the latest earnings results for Lantheus Holdings Inc.Capitalize on proven investment strategies - jammulinksnews.com
How strong is Lantheus Holdings Inc. company’s balance sheetStock Market Review That Work - jammulinksnews.com
What is Lantheus Holdings Inc. company’s growth strategyCapitalize on market trends with confidence - jammulinksnews.com
What catalysts could drive Lantheus Holdings Inc. stock higher in 2025Discover stocks with superior performance - jammulinksnews.com
Does Lantheus Holdings Inc. stock perform well during market downturnsUnlock powerful portfolio optimization tools - jammulinksnews.com
What are analysts’ price targets for Lantheus Holdings Inc. in the next 12 monthsAchieve consistent profits with disciplined trading - jammulinksnews.com
Lantheus Completes Acquisition of Life Molecular Imaging, Supports Alzheimer’s Diagnostics with Neuraceq, New R&D Head - Insider Monkey
How Lantheus Holdings Inc. stock reacts to Fed policy changesFree Consultation - jammulinksnews.com
10 Most Undervalued Stocks to Buy and Hold for 3 Years - Insider Monkey
Bedford life sciences company Lantheus expands with new lease - The Business Journals
11 Best Long Term Low Risk Stocks to Invest in - Insider Monkey
What drives Lantheus Holdings Inc. stock priceHigh-velocity capital appreciation - Autocar Professional
What analysts say about Lantheus Holdings Inc. stockDynamic growth stocks - Autocar Professional
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Lantheus Sets Q2 2025 Earnings Call Date: How to Join and What to Expect on August 6 - Stock Titan
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT - MSN
Lantheus Holdings Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Is Lantheus Holdings Inc. a good long term investmentExceptional stock performance - jammulinksnews.com
Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet? - 富途牛牛
Lantheus Completes Acquisition of Life Molecular Imaging, Names New Head of R&D. - AInvest
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D - The Manila Times
Lantheus Holdings Completes Acquisition of Life Molecular Imaging, Appoints Dr. Ludger Dinkelborg as Head of R&D - Nasdaq
Lantheus Holdings: Forget The Short Term Noise (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.12%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):